Scientific inquiry continues to uncover the intricate molecular pathways through which berberine exerts its beneficial metabolic effects, emphasizing its capacity to enhance GLP-1 secretion and modulate critical physiological processes (Weili Yang et al., 2024)
In cardiovascular outcome trials of semaglutide in type 2 diabetes, rapid improvements in glycemic control were associated with an increased rate of diabetic retinopathy complications in high-risk patients, likely reflecting the well-known phenomenon of transient retinopathy worsening when glucose control improves quickly.9 More recently, observational analyses and pharmacovigilance reports have raised a possible association between semaglutide exposure and nonarteritic anterior ischemic optic neuropathy (NAION), leading to ongoing regulatory review
Industry analysts note: In the future, only products that deliver unique valuewhether through formulation, target, indication, or safety profilewill have the chance to stand out in fierce competition and drive, or even lead, the industry forward. The GLP-1 market, dominated by a duopoly, has become saturated, but research on emerging targets such as Amylin, ACVR2A, ACTR2B, FGF21, and ACSL5 continues to make breakthroughs
Allergic Reactions For some individuals, a skin rash is a clear sign of an allergic reaction to the supplement itself
However, its crucial to understand that stopping the medication may lead to weight gain, and the most successful weight loss outcomes come from long-term use and lifestyle changes
